Showing results (131-140 of 173) with videos related to

Sort By:
Pageof 18
BMC Medical Genetics|August 20, 2017
Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targetsYasushi Horimasu, Nobuhisa Ishikawa, Masaya Taniwaki, et al.
Journal of Cellular and Molecular Medicine|February 9, 2019
Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblastsTakeshi Masuda, Taku Nakashima, Masashi Namba, et al.
Respiratory Research|June 13, 2020
Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosisKakuhiro Yamaguchi, Hiroshi Iwamoto, Witold Mazur, et al.
Molecular Cancer Therapeutics|November 6, 2025
Plasminogen Activator Inhibitor-1 Mediates Tolerance to Anti-PD-1 Immunotherapy in Non-Small Cell Lung CancerMasahiko Sumii, Takeshi Masuda, Kiyofumi Shimoji, et al.
Journal of Translational Medicine|November 28, 2023
Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progressionKiyofumi Shimoji, Taku Nakashima, Takeshi Masuda, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinomaKentaro Tokumo, Takeshi Masuda, Takahiko Miyama, et al.
Molecular Therapy. Nucleic Acids|August 10, 2018
Intratracheal Administration of siRNA Dry Powder Targeting Vascular Endothelial Growth Factor Inhibits Lung Tumor Growth in MiceKei Miwata, Hirokazu Okamoto, Taku Nakashima, et al.
Respirology (Carlton, Vic.)|March 22, 2006
Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosisAkihito Yokoyama, Keiichi Kondo, Masamitsu Nakajima, et al.
Respiratory Investigation|June 29, 2019
Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancerYu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi, et al.
International Journal of Oncology|August 28, 2012
Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesotheliomaJun Kurai, Hiroki Chikumi, Kiyoshi Hashimoto, et al.
Pageof 18